hypoxanthine has been researched along with Clerambault Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachmann, B; Fritz, T; Hempelmann, G; Kuhn, DF; Oehmke, MJ | 1 |
Agren, H; Akerström, G; Hetta, J; Joborn, C; Ljunghall, S; Niklasson, F; Rastad, J; Wide, L | 1 |
2 other study(ies) available for hypoxanthine and Clerambault Syndrome
Article | Year |
---|---|
[A possible risk for geriatric risk patients caused by intraoperative disorder of cerebral energy utilization?].
Topics: Aged; Anesthesia, Spinal; Blood-Brain Barrier; Brain Ischemia; Creatine Kinase; Dementia, Vascular; Energy Metabolism; Female; Hip Prosthesis; Humans; Hypoxanthine; Hypoxanthines; Intraoperative Complications; Lactates; Lactic Acid; Male; Middle Aged; Monitoring, Intraoperative; Neurocognitive Disorders; Neuroleptanalgesia; Phosphopyruvate Hydratase; Reoperation | 1994 |
Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.
Topics: Blood-Brain Barrier; Calcium; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hyperparathyroidism; Hypoxanthine; Hypoxanthines; Methoxyhydroxyphenylglycol; Neurocognitive Disorders; Parathyroid Glands; Parathyroid Hormone; Serum Albumin; Xanthine; Xanthines | 1991 |